quarta-feira, 7 de outubro de 2026
PesquisarExplore
pt.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 28, 2026

UPS Releases 1Q 2026 Earnings

View original at finance.yahoo.com
“U.S. Domestic Segment 1Q 2026 Revenue $14,125 M”
Verbatim excerpt from the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • UPS expects to return to consolidated revenue and operating profit growth, and adjusted operating margin expansion in Q2 2026.

    60% confidence

  • U.S. Domestic Segment revenue declined 2.3% in Q1 2026, primarily driven by an expected decline in volume, while revenue per piece grew 6.5%.

    60% confidence

  • Supply Chain Solutions revenue declined 6.5% in Q1 2026, primarily due to a decline in volume in the Mail Innovations business.

    60% confidence

  • UPS reaffirms its full year 2026 financial guidance.

    60% confidence

  • International Segment revenue increased 3.8% in Q1 2026, driven by a 10.7% increase in revenue per piece.

    60% confidence

  • UPS employees around the world have worked hard and pushed the company's transformation forward.

    60% confidence

  • Q1 2026 was a critical transition period requiring flawless execution of several major strategic actions, which UPS successfully delivered.

    60% confidence

Data points we hold from this source

United Parcel Service · margin non gaap adjusted6.2 percent
United Parcel Service · eps non gaap adjusted1.07 USD
United Parcel Service · transformation charges after tax42 USD
United Parcel Service · net income1.27 USD
United Parcel Service · net income non gaap adjusted1.32 USD
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
UPS Releases 1Q 2026 Earnings — Source | Via News | pt.VIA.NEWS